Categories: News

Milestone Scientific Schedules 2022 Year-End Financial Results and Business Update Conference Call

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

ROSELAND, N.J., March 29, 2023 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, March 31, 2023, to discuss the company’s financial results for 2022, as well as the company’s corporate progress and other developments.

The conference call will be available via telephone by dialing toll free 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and by entering the access code: 333430. A webcast and replay of the call may be accessed at https://www.webcaster4.com/Webcast/Page/2306/47967.

An audio replay of the call will be available through April 15, 2023, and can be accessed by dialing 877-481-4010 for U.S. callers or +1 919-882-2331 for international callers and by entering the access code: 45018.

About Milestone Scientific Inc.

Milestone Scientific Inc. (MLSS), a technology-focused medical research and development company that patents, designs and develops innovative injection technologies and instruments for medical, dental and cosmetic applications. Milestone Scientific’s computer-controlled systems are designed to make injections precise, efficient and increase the overall patient comfort and safety. Their proprietary DPS Dynamic Pressure Sensing Technology® instruments is the platform to advance the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions of subcutaneous drug delivery, including local anesthetic. To learn more, view the MLSS brand video or visit milestonescientific.com.

Contact:
Crescendo Communications, LLC
Email: mlss@crescendo-ir.com
Tel: 212-671-1020

Staff

Recent Posts

Neural Therapeutics Announces SERFOR Permit Renewal Submission and Extension of LOI with HANF.COM

Toronto, Ontario--(Newsfile Corp. - May 9, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural"…

35 minutes ago

SAB BIO Announces Q1 2025 Financial Results and Provides Company Updates

MIAMI, May 09, 2025 (GLOBE NEWSWIRE) -- SAB BIO (Nasdaq: SABS), (“SAB BIO” or the “Company”),…

35 minutes ago

NEXGEL to Report First Quarter 2025 Financial Results on May 13th

Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE,…

35 minutes ago

Outset Medical to Present at RBC Global Healthcare Conference

SAN JOSE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”),…

35 minutes ago

SRx Health Solutions Purchases $1.5 Million of Solana Tokens as Part of its Asset Allocation Diversification Strategy

TAMPA, Fla., May 09, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH)…

36 minutes ago

Best Bodybuilding Supplements: Top Legal Steroids & Supplements For Bodybuilding & Muscle Growth

Backed by Wolfson Brands (UK) Limited, discover proven bodybuilding supplements & legal steroids that actually…

36 minutes ago